{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31837261", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "03"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.12659/MSM.919203"], "Journal": {"ISSN": "1643-3750", "JournalIssue": {"Volume": "25", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "14"}}, "Title": "Medical science monitor : international medical journal of experimental and clinical research", "ISOAbbreviation": "Med Sci Monit"}, "ArticleTitle": "The Effects of Orientin on Proliferation and Apoptosis of T24 Human Bladder Carcinoma Cells Occurs Through the Inhibition of Nuclear Factor-kappaB and the Hedgehog Signaling Pathway.", "Pagination": {"StartPage": "9547", "EndPage": "9554", "MedlinePgn": "9547-9554"}, "Abstract": {"AbstractText": ["BACKGROUND Orientin is a flavone isolated from medicinal plants used in traditional Chinese medicine (TCM), which suppresses the growth of cancer cells in vitro. The effects of orientin in bladder cancer cells remains unknown. This study aimed to investigate the effect of orientin on proliferation and apoptosis of T24 human transitional cell bladder carcinoma cells in vitro in the presence of an agonist and an inhibitor of nuclear factor-kappaB (NF-kappaB). MATERIAL AND METHODS T24 cells were cultured and divided into four study groups: an untreated control group; a group treated with 100 \u03bcM orientin; a group treated with 100 \u03bcM orientin with NF-kappaB agonist, phorbol 12-myristate 13-acetate (PMA); and a group treated with 100 \u03bcM orientin and the NF-kappaB inhibitor, IkappaBalpha. The MTT assay was performed to assess cell viability, and flow cytometry evaluated the cell cycle. The expression of proteins in the Hedgehog signaling pathway and inflammatory cytokines were determined by Western blot and enzyme-linked immunosorbent assay (ELISA). RESULTS Orientin inhibited the proliferation of T24 cells, caused cell cycle arrest, reduced cell viability, and inhibited the expression of inflammatory mediators. Treatment of T24 cells with orientin inhibited the expression of NF-kappaB and components of the Hedgehog signaling pathway, and the NF-kappaB agonist, PMA, reversed these effects. CONCLUSIONS Treatment of T24 human bladder carcinoma cells in vitro with orientin inhibited cell proliferation and promoted cell apoptosis by suppressing the Hedgehog signaling pathway and NF-kappaB."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Tian", "ForeName": "Fenghao", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urological Surgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Tong", "ForeName": "Ming", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urological Surgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Li", "ForeName": "Zizhi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urological Surgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Huang", "ForeName": "Weichao", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urological Surgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Jin", "ForeName": "Yanyang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urological Surgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Cao", "ForeName": "Qingfei", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Zhou", "ForeName": "Xiaoli", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urological Surgery, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China (mainland)."}], "LastName": "Tong", "ForeName": "Guangquan", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Sci Monit", "NlmUniqueID": "9609063", "ISSNLinking": "1234-1010"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hedgehog Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "I-kappa B Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "IAX93XCW6C", "NameOfSubstance": "orientin"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Glucosides"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hedgehog Proteins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "I-kappa B Proteins"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Urinary Bladder"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Urinary Bladder Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239\u201349.", "ArticleIdList": ["19520422"]}, {"Citation": "Chen X, Wang P, Wang S, et al. CIZ1 knockdown suppresses the proliferation of bladder cancer cells by inducing apoptosis. Gene. 2019;719:143946.", "ArticleIdList": ["31252164"]}, {"Citation": "Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300\u201310.", "ArticleIdList": ["26346676"]}, {"Citation": "National Institute for Health and Care Excellence (NICE) guidance (2015) Bladder cancer: Diagnosis and management of bladder cancer. BJU Int. 2017;120(6):755\u201365.", "ArticleIdList": ["26180884"]}, {"Citation": "Bhanvadia SK. Bladder cancer survivorship. Curr Urol Rep. 2018;19(12):111.", "ArticleIdList": ["30414013"]}, {"Citation": "Martinez Rodriguez RH, Buisan Rueda O, Ibarz L. Bladder cancer: Present and future. Med Clin (Barc) 2017;149(10):449\u201355.", "ArticleIdList": ["28736063"]}, {"Citation": "Vasekar M, Degraff D, Joshi M. Immunotherapy in bladder cancer. Curr Mol Pharmacol. 2016;9(3):242\u201351.", "ArticleIdList": ["26177642"]}, {"Citation": "Nishiyama H. Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer. Jpn J Clin Oncol. 2018;48(1):3\u20136.", "ArticleIdList": ["29145591"]}, {"Citation": "Grayson M. Bladder cancer. Nature. 2017;551(7679):S33.", "ArticleIdList": ["29117156"]}, {"Citation": "Berdik C. Unlocking bladder cancer. Nature. 2017;551:S34.", "ArticleIdList": ["29117159"]}, {"Citation": "Cui X, Shen D, Kong C, et al. NF-kappaB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo. Sci Rep. 2017;7:40723.", "ArticleIdList": ["PMC5282527", "28139689"]}, {"Citation": "Kamat AM, Tharakan ST, Sung B, Aggarwal BB. Curcumin potentiates the antitumor effects of bacillus calmette-guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors. Cancer Res. 2009;69(23):8958\u201366.", "ArticleIdList": ["19903839"]}, {"Citation": "Mamtani R, Yang YX, Scott FI, et al. Association of itraconazole, a hedgehog inhibitor, and bladder cancer. J Urol. 2016;196(2):343\u201348.", "ArticleIdList": ["PMC4958604", "26812305"]}, {"Citation": "Tian T, Zeng J, Zhao G, et al. Neuroprotective effects of orientin on oxygen-glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons. Exp Biol Med. 2018;243(1):78\u201386.", "ArticleIdList": ["PMC5788155", "29073777"]}, {"Citation": "Lam KY, Ling AP, Koh RY, et al. A review on medicinal properties of orientin. Adv Pharmacol Sci. 2016;2016 4104595.", "ArticleIdList": ["PMC4889806", "27298620"]}, {"Citation": "Czemplik M, Mierziak J, Szopa J, Kulma A. Flavonoid C-glucosides derived from flax straw extracts reduce human breast cancer cell growth in vitro and induce apoptosis. Front Pharmacol. 2016;7:282.", "ArticleIdList": ["PMC5006111", "27630565"]}, {"Citation": "Law BN, Ling AP, Koh RY, et al. Neuroprotective effects of orientin on hydrogen peroxide-induced apoptosis in SHSY5Y cells. Mol Med Rep. 2014;9(3):947\u201354.", "ArticleIdList": ["24366367"]}, {"Citation": "Thangaraj K, Natesan K, Settu K, et al. Orientin mitigates 1, 2-dimethylhydrazine induced lipid peroxidation, antioxidant and biotransforming bacterial enzyme alterations in experimental rats. J Cancer Res Ther. 2018;14(6):1379\u201388.", "ArticleIdList": ["30488860"]}, {"Citation": "An F, Wang S, Tian Q, Zhu D. Effects of orientin and vitexin from Trollius chinensis on the growth and apoptosis of esophageal cancer EC-109 cells. Oncol Lett. 2015;10(4):2627\u201333.", "ArticleIdList": ["PMC4580036", "26622901"]}, {"Citation": "Kim SJ, Pham TH, Bak Y, et al. Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKCalpha/ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells. Phytomedicine. 2018;50:35\u201342.", "ArticleIdList": ["30466990"]}, {"Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. Cancer J Clin. 2015;65(1):5\u201329.", "ArticleIdList": ["25559415"]}, {"Citation": "Pang C, Guan Y, Li H, et al. Urologic cancer in China. Jpn J Clin Oncol. 2016;46(6):497\u2013501.", "ArticleIdList": ["27049022"]}, {"Citation": "Khan F, Sharma P, Prakash O, et al. Structure-activity relationship studies on holy basil (Ocimum sanctum L.) based flavonoid orientin and its analogue for cytotoxic activity in liver cancer cell line HepG2. Comb Chem High Throughput Screen. 2016;19(8):656\u201366.", "ArticleIdList": ["27396915"]}, {"Citation": "An F, Wang S, Tian Q, Zhu D. Effects of orientin and vitexin from Trollius chinensis on the growth and apoptosis of esophageal cancer EC-109 cells. Oncol Lett. 2015;10(4):2627\u201333.", "ArticleIdList": ["PMC4580036", "26622901"]}, {"Citation": "Czemplik M, Mierziak J, Szopa J, Kulma A. Flavonoid C-glucosides derived from flax straw extracts reduce human breast cancer cell growth in vitro and induce apoptosis. Front Pharmacol. 2016;7:282.", "ArticleIdList": ["PMC5006111", "27630565"]}, {"Citation": "Xia Y, Shen S, Verma IM. NF-\u03baB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823\u201330.", "ArticleIdList": ["PMC4155602", "25187272"]}, {"Citation": "Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431\u201336.", "ArticleIdList": ["16724054"]}, {"Citation": "Kim YR, Kim I-J, Kang TW, et al. HOXB13 downregulates intracellular zinc and increases NF-\u03baB signaling to promote prostate cancer metastasis. Oncogene. 2014;33(37):4558\u201367.", "ArticleIdList": ["24096478"]}, {"Citation": "Jiang L, Lin C, Song L, et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-\u03baB/I\u03baB\u03b1 negative feedback loop. J Clin Invest. 2012;122(1):33\u201347.", "ArticleIdList": ["PMC3248293", "22156201"]}, {"Citation": "Thangaraj K, Vaiyapuri M. Orientin, a C-glycosyl dietary flavone, suppresses colonic cell proliferation and mitigates NF-\u03baB mediated inflammatory response in 1,2-dimethylhydrazine induced colorectal carcinogenesis. Biomed Pharmacother. 2017;96:1253\u201366.", "ArticleIdList": ["29198745"]}, {"Citation": "Kasperczyk H, Baumann B, Debatin K-M, Fulda S. Characterization of sonic hedgehog as a novel NF-\u03baB target gene that promotes NF-\u03baB-mediated apoptosis resistance and tumor growth in vivo. FASEB J. 2009;23(1):21\u201333.", "ArticleIdList": ["18772349"]}, {"Citation": "Nakashima H, Nakamura M, Yamaguchi H, et al. Nuclear factor-B contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res. 2006;66(14):7041\u201349.", "ArticleIdList": ["16849549"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["31837261", "PMC6929549", "10.12659/MSM.919203", "919203"]}}]}